Effect of pravastatin treatment on glucose, insulin, and lipoprotein metabolism in patients with hypercholesterolemia
- 28 February 1994
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 127 (2) , 331-336
- https://doi.org/10.1016/0002-8703(94)90121-x
Abstract
No abstract availableKeywords
Funding Information
- National Health Research Institutes (HL 08506)
- Institute of Biomedical Science
- National Science Council (82-0412-B016-1071)
- Academia Sinica
This publication has 16 references indexed in Scilit:
- Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Insulin resistance in familial and nonfamilial hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)The American Journal of Cardiology, 1992
- Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.BMJ, 1992
- Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.Circulation, 1992
- Efficacy and safety of pravastatin in patients with primary hypercholesterolemiaAtherosclerosis, 1990
- CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall StudyThe Lancet, 1980
- Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in FinlandDiabetes Care, 1979
- Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetesJournal of Clinical Investigation, 1970
- A comparison of heritable abnormal lipoprotein patterns as defined by two different techniquesJournal of Clinical Investigation, 1968